Area of research
Radiology, Nuclear Medicine and Imaging · Molecular Biology
Research interest
Research interests include Radiomics and Machine Learning in Medical Imaging, RNA modifications and cancer, Advanced Radiotherapy Techniques, and Ferroptosis and cancer prognosis.
Genomic mutation profile and metabolic alterations in diffuse large B-cell lymphoma with abdominal bulky mass
764 | REAL‐WORLD OUTCOMES OF MITOXANTRONE HYDROCHLORIDE LIPOSOME REGIMEN FOR PERIPHERAL T‐CELL LYMPHOMA: THE EFFICACY AND SAFETY ANALYSIS OF TREATMENT‐NAÏVE POPULATION
Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial
Mutually aided uncertainty incorporated dual consistency regularization with pseudo label for semi-supervised medical image segmentation
A Novel Role of ARA70 in Regulating Ferritinophagy of RGCs During Retinal Ischemia Reperfusion
Identification of leukocyte-lymphocyte ratio as a novel prognostic factor in Peripheral T-cell lymphoma
Corrigendum re “Periurethral Injection of Autologous Adipose-Derived Stem Cells with Controlled-Release Nerve Growth Factor for the Treatment of Stress Urinary Incontinence in a Rat Model” [Eur Urol 2011;59:155–63]
Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway
Silencing circular RNA circZNF609 restrains growth, migration and invasion by up-regulating microRNA-186-5p in prostate cancer
RETRACTED: CircLMTK2 acts as a tumor suppressor in prostate cancer via regulating the expression of microRNA-183
The downregulated long noncoding RNA <em>DHRS4-AS1</em> is protumoral and associated with the prognosis of clear cell renal cell carcinoma
HDAC6 serves as a biomarker for the prognosis of patients with renal cell carcinoma
High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma